Mark Sheptoff Financial Planning LLC reduced its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,852 shares of the healthcare product maker’s stock after selling 600 shares during the quarter. […]
Citizens & Northern Corp trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,321 shares of the healthcare product maker’s stock after selling 971 shares during the period. Abbott Laboratories accounts […]
Keb Asset Management LLC raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,896 shares of the healthcare product maker’s stock after buying an additional 312 shares during the period. Keb Asset Management […]
Oxler Private Wealth LLC decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 58.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,397 shares of the healthcare product maker’s stock after selling 10,340 shares during the quarter. Abbott […]
Sand Hill Global Advisors LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.8% in the fourth quarter, Holdings Channel reports. The firm owned 69,171 shares of the healthcare product maker’s stock after acquiring an additional 550 shares during the period. Sand Hill Global Advisors LLC’s holdings in Abbott Laboratories […]